Table 3.
Association between clinical pathologic variables and postoperative bleeding in patients with malignant disease.
| Variables | Postoperative bleeding | Chi-square test | Multivariate analysis | ||
|---|---|---|---|---|---|
| Yes | No | p | HR [95% CI] | ||
| Age | |||||
| ≥50 | 142 (54.0%) | 15,222 (56.5%) | |||
| <50 | 121 (46.0%) | 11,700 (43.5%) | 0.407 | ||
| Sex | |||||
| Female | 215 (81.7%) | 21,438 (79.6%) | |||
| Male | 48 (19.3%) | 5,484 (20.4%) | 0.396 | ||
| Smoker | |||||
| Yes | 35 (13.3%) | 3,985 (14.8%) | |||
| No | 228 (86.7%) | 22,937 (85.2%) | 0.497 | ||
| Drinker | |||||
| No | 208 (79.1%) | 23,338 (86.7%) | |||
| Yes | 55 (20.9%) | 3,584 (13.3%) | <0.001 | 0.245 | 1.887 [0.896–2.006] |
| Hypertension | |||||
| No | 193 (73.4%) | 21,800 (81.0%) | |||
| Yes | 70 (26.6%) | 5,122 (19.0%) | 0.001 | <0.001 | 1.553 [1.034–2.117] |
| Diabetes | |||||
| No | 209 (79.5%) | 22,701 (84.3%) | |||
| Yes | 54 (20.5%) | 4,221 (15.7%) | 0.031 | <0.001 | 1.468 [1.104–2.004] |
| BMI | |||||
| <24 | 181 (68.8%) | 16,576 (61.6%) | |||
| 24-28 | 62 (23.6%) | 7,120 (26.4%) | <0.001 | 1.463 [1.078–1.998] | |
| ≥28 | 20 (7.6%) | 3,226 (12.0%) | <0.001 | <0.001 | 2.110 [1.547–2.997] |
| Chemotherapy | |||||
| No | 251 (95.4%) | 26,289 (97.6%) | |||
| Yes | 12 (4.6%) | 633 (2.4%) | 0.019 | 0.098 | 1.887 [0.987–2.412] |
| Radiotherapy | |||||
| Yes | 6 (2.3%) | 445 (1.7%) | |||
| No | 257 (97.7%) | 26,477 (98.3%) | 0.458 | ||
| LMWHR* | |||||
| Yes | 30 (11.4%) | 2,997 (11.1%) | |||
| No | 233 (88.6%) | 23,925 (88.9%) | 0.888 | ||
| Operation time | |||||
| <2 h | 108 (41.1%) | 15,812 (58.7%) | |||
| ≥2 h | 155 (58.9%) | 11,110 (41.3%) | <0.001 | <0.001 | 1.557 [1.075–1.999] |
| Tumor stage | |||||
| T1+T2 | 97 (36.9%) | 14,555 (54.1%) | |||
| T3+T4 | 166 (63.1%) | 12,367 (45.9%) | <0.001 | <0.001 | 2.345 [1.567–3.669] |
| Lateral neck dissection | |||||
| No | 156 (59.3%) | 15,256 (56.7%) | |||
| Unilateral | 73 (27.8%) | 7,566 (28.1%) | |||
| Bilateral | 34 (12.9%) | 4,100 (15.2%) | <0.001 | 0.112 | 1.947 [0.913–2.664] |
| Pathology | |||||
| Papillary carcinoma | 261 (99.2%) | 26,700 (99.2%) | |||
| Others | 2 (0.8%) | 222 (0.8%) | 1.000 | ||
| Tracheotomy | |||||
| No | 255 (97.0%) | 26,749 (99.4%) | |||
| Yes | 8 (3.0%) | 173 (0.6%) | <0.001 | <0.001 | 1.765 [1.114–2.132] |
LMWHR, low-molecular-weight heparin replacement.